Filing Details

Accession Number:
0001104659-21-020033
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-10 20:01:02
Reporting Period:
2021-02-08
Accepted Time:
2021-02-10 20:01:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1069899 Phibro Animal Health Corp PAHC Pharmaceutical Preparations (2834) 131840497
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1603584 Lee Larry Miller 300 Frank W. Burr Blvd.
Ste 21
Teaneck NJ 07666
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-02-08 50,000 $0.00 50,000 No 4 M Direct
Class A Common Stock Disposition 2021-02-09 20,000 $22.94 30,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Restricted Stock Units Disposition 2021-02-08 250,000 $0.00 250,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Shares were issued in settlement of restricted stock units ("RSUs"). Each RSU represented a contingent right to receive one share of Class A Common Stock.
  2. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.59 to $23.20, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. RSUs were granted on May 7, 2018, 50,000 RSUs vested on December 31, 2020 and 200,000 performance-based RSUs were cancelled for not meeting the performance requirement. Vested shares were delivered on February 8, 2021.